Musk says Neuralink's Blindsight implant is engineering-complete, awaits regulators
Elon Musk announced on X that Neuralink's second implant, Blindsight, is finished from an engineering perspective and now only needs regulatory approval. He claims the device could restore sight to people who are completely blind or have never seen, including those without prior vision. This follows Neuralink's first product, Telepathy, which lets users control computers by thought and has already been used by a patient to play World of Warcraft.
GoKawiil's interpretation of the reporting above, not reported fact.
If Musk's claims hold up under regulatory review, Blindsight would mark a departure from most brain-computer interfaces, which read signals out of the brain rather than feeding sensory input in, potentially opening a new category of neuroprosthetic devices. The announcement also keeps Neuralink ahead of rivals like Meta and China's NeuroXess in a fast-moving BCI race, though no independent data or trial results have been disclosed to verify the device's real-world performance.
- Musk claims Blindsight is engineering-complete and pending only regulatory clearance.
- The device aims to restore sight even for people born blind, unlike existing BCIs that mainly send brain signals outward.
- Neuralink faces competition from Meta's non-invasive scanner and China's NeuroXess, both pursuing similar brain-interface technology.
Source: tomshardware.com — Jowi Morales, 2026-11-01
Published there as: “Elon Musk says Neuralink's 'BlindSight' is ready to cure blindness”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.